 MINNEAPOLIS, June 22, 2021 GLOBE NEWSWIRE -- Predictive Oncology NASDAQ: POAI, an AI-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, Soluble Biotech Inc. and TumorGenesis Inc. are both expanding their unique services by completing the fabrication and qualification of GMP facilities. 